Article Text
PostScript
Letter
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
Statistics from Altmetric.com
Footnotes
-
Funding Supported by grants from the National Scientific and Technological Major Project (2012ZX10002-005); and acknowledgement of Taiwan Liver Consortium for patients recruitment.
-
Competing interests P-J Chen is a consultant for Novartis and Roche. D-S Chen is a consultant for Novartis and GlaxoSmithKline. J-H Kao is a consultant for Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Omrix, and Roche; and is a member of the Speaker's Bureau for Roche, Bristol-Myers Squibb, GlaxoSmithKline, and Novartis.
-
Patient consent Obtained.
-
Ethics approval This study was approved by the Ethics Committees of Zhongshan Hospital of Xiamen University.
-
Provenance and peer review Not commissioned; externally peer reviewed.